Cargando…

Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR

Pharmacologic reversal of serious or intolerable side effects (SISEs) from vasodilator stress is an important safety and comfort measure for patients experiencing such effects. While typically performed using intravenous aminophylline, recurrent shortages of this agent have led to a greater need to...

Descripción completa

Detalles Bibliográficos
Autores principales: Abidov, Aiden, Dilsizian, Vasken, Doukky, Rami, Duvall, W. Lane, Dyke, Christopher, Elliott, Michael D., Hage, Fadi G., Henzlova, Milena J., Johnson, Nils P., Schwartz, Ronald G., Thomas, Gregory S., Einstein, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517353/
https://www.ncbi.nlm.nih.gov/pubmed/30574677
http://dx.doi.org/10.1007/s12350-018-01548-0
_version_ 1783418257814847488
author Abidov, Aiden
Dilsizian, Vasken
Doukky, Rami
Duvall, W. Lane
Dyke, Christopher
Elliott, Michael D.
Hage, Fadi G.
Henzlova, Milena J.
Johnson, Nils P.
Schwartz, Ronald G.
Thomas, Gregory S.
Einstein, Andrew J.
author_facet Abidov, Aiden
Dilsizian, Vasken
Doukky, Rami
Duvall, W. Lane
Dyke, Christopher
Elliott, Michael D.
Hage, Fadi G.
Henzlova, Milena J.
Johnson, Nils P.
Schwartz, Ronald G.
Thomas, Gregory S.
Einstein, Andrew J.
author_sort Abidov, Aiden
collection PubMed
description Pharmacologic reversal of serious or intolerable side effects (SISEs) from vasodilator stress is an important safety and comfort measure for patients experiencing such effects. While typically performed using intravenous aminophylline, recurrent shortages of this agent have led to a greater need to limit its use and consider alternative agents. This information statement provides background and recommendations addressing indications for vasodilator reversal, timing of a reversal agent, incidence of observed SISE with vasodilator stress, clinical and logistical considerations for aminophylline-based reversal, and alternative non-aminophylline based reversal protocols. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12350-018-01548-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6517353
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-65173532019-06-05 Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR Abidov, Aiden Dilsizian, Vasken Doukky, Rami Duvall, W. Lane Dyke, Christopher Elliott, Michael D. Hage, Fadi G. Henzlova, Milena J. Johnson, Nils P. Schwartz, Ronald G. Thomas, Gregory S. Einstein, Andrew J. J Nucl Cardiol ASNC Information Statement Pharmacologic reversal of serious or intolerable side effects (SISEs) from vasodilator stress is an important safety and comfort measure for patients experiencing such effects. While typically performed using intravenous aminophylline, recurrent shortages of this agent have led to a greater need to limit its use and consider alternative agents. This information statement provides background and recommendations addressing indications for vasodilator reversal, timing of a reversal agent, incidence of observed SISE with vasodilator stress, clinical and logistical considerations for aminophylline-based reversal, and alternative non-aminophylline based reversal protocols. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12350-018-01548-0) contains supplementary material, which is available to authorized users. Springer International Publishing 2018-12-20 2019 /pmc/articles/PMC6517353/ /pubmed/30574677 http://dx.doi.org/10.1007/s12350-018-01548-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle ASNC Information Statement
Abidov, Aiden
Dilsizian, Vasken
Doukky, Rami
Duvall, W. Lane
Dyke, Christopher
Elliott, Michael D.
Hage, Fadi G.
Henzlova, Milena J.
Johnson, Nils P.
Schwartz, Ronald G.
Thomas, Gregory S.
Einstein, Andrew J.
Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR
title Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR
title_full Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR
title_fullStr Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR
title_full_unstemmed Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR
title_short Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR
title_sort aminophylline shortage and current recommendations for reversal of vasodilator stress: an asnc information statement endorsed by scmr
topic ASNC Information Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517353/
https://www.ncbi.nlm.nih.gov/pubmed/30574677
http://dx.doi.org/10.1007/s12350-018-01548-0
work_keys_str_mv AT abidovaiden aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT dilsizianvasken aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT doukkyrami aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT duvallwlane aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT dykechristopher aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT elliottmichaeld aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT hagefadig aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT henzlovamilenaj aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT johnsonnilsp aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT schwartzronaldg aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT thomasgregorys aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT einsteinandrewj aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr